Mother–Daughter Communication About HPV Vaccine by McRee, Annie-Laurie et al.
Mother-daughter communication about HPV vaccine
Annie-Laurie McRee, M.P.Ha, Paul L. Reiter, Ph.D.a,b, Sami L. Gottlieb, M.D.,M.S.P.Hc, and
Noel T. Brewer, Ph.D.a,b
aUNC Gillings School of Global Public Health, Centers for Disease Control and Prevention
bLineberger Comprehensive Cancer Center, Centers for Disease Control and Prevention
cDivision of STD Prevention, Centers for Disease Control and Prevention
Abstract
Purpose—Parent-child conversations about HPV vaccine may provide parents with
opportunities to talk with their daughters about sexual health. We sought to characterize mothers’
communication with their adolescent daughters about HPV vaccine.
Methods—We surveyed 609 mothers of girls aged 11–20 living in North Carolina in fall 2008.
We used logistic regression to identify correlates of mother-daughter communication.
Results—Most mothers (81%) reported discussing HPV vaccine with their daughters. For almost
half of these families (47%), discussing HPV vaccine led to a conversation about sex. This was
more common among mothers who believed their daughters may be sexually active (OR: 1.88,
95%CI: 1.25–2.83), had greater knowledge of HPV vaccine (OR: 2.46, 95%CI: 1.07–5.64), lived
in urban areas (OR: 1.75, 95%CI: 1.21–2.54), or reported being born-again Christians (OR: 1.74,
95%CI: 1.17–2.58). Most mothers who talked with their daughters about HPV vaccine reported
discussing reasons for and against getting vaccinated (86%). Mothers most commonly reported
discussing potential HPV vaccine benefits, usually protection against cervical cancer (56%), and
less frequently reported discussing perceived negatives of HPV vaccine.
Conclusions—HPV vaccine conversations may provide opportunities for sexual health
promotion and STI prevention.
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Current guidelines recommend routine human papillomavirus (HPV) vaccination for
adolescent girls aged 11–12 with catch-up vaccination for girls and women aged 13–26 [1].
While many adolescents make HPV vaccination decisions along with their parents [2,3], we
know little about parents’ conversations with their daughters about HPV vaccine. As HPV is
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a sexually transmitted infection (STI), HPV vaccine conversations may provide parents with
natural opportunities to talk with their daughters about sexual health and STI prevention.
This is important because parent-child communication about sex, particularly mother-
daughter communication, is associated with decreased adolescent sexual risk taking and, like
HPV vaccination, is most beneficial if it occurs before sexual debut [4,5]. The purpose of
this study was to characterize mothers’ communication with their adolescent daughters
about HPV vaccine and whether these conversations lead to discussions about sex.
Methods
We report the methods for our study in detail elsewhere [6]. At baseline, trained personnel
used computer-assisted telephone interviewing equipment to survey caregivers for females
aged 10 to 18 years in southeastern North Carolina counties with elevated rates of cervical
cancer. Of 1,220 eligible caregivers contacted, 889 (73%) completed baseline telephone
interviews between July and October 2007. Interviewers re-contacted 650 (74%) of eligible
baseline respondents by telephone during fall 2008. Data for the present study are from 609
female caregivers who provided information at follow-up about communication with their
daughters, who were by then aged 11–20. We excluded data from male caregivers (n=38)
and respondents who provided only partial data (n=3). Because the majority of caregivers
(96%) reported being the child’s parent, for the sake of simplicity, we refer to all
respondents as mothers. The University of North Carolina Institutional Review Board
approved the study.
The survey is available at http://www.unc.edu/~ntbrewer/hpv.htm. The primary outcomes
were mothers’ report of communicating with their daughters about HPV vaccine, and
whether talking about HPV vaccine led to a discussion about sex. Interviewers asked
whether mothers had discussed reasons for or against getting HPV vaccine, followed by an
open-ended question assessing content, “What did you discuss?” The survey also assessed
beliefs about HPV vaccine and characteristics of daughters, mothers and their households
that may be associated with communication.
Data analysis
We first used logistic regression to identify bivariate correlates of whether mothers had
talked with their daughters about HPV vaccine, and then conducted a multivariate regression
using all variables associated (p<.10) in bivariate analyses. We repeated this two-step
regression approach for discussions about sex as a result of discussing HPV vaccine. Finally,
we examined content of HPV vaccine discussions, assessing differences by whether the
daughter was vaccinated using chi-square analyses. Analyses used Stata SE version 10.0
(Statacorp, College Station, TX).
Results
Most mothers (81%, 496/609) reported having talked about HPV vaccine with their
adolescent daughters (Table 1). In multivariate analyses, communication about HPV vaccine
was more likely among mothers whose daughters had been vaccinated, who had received a
doctor’s recommendation to get their daughters HPV vaccine, or who had greater knowledge
of HPV vaccine. Communication was also more likely among mothers with daughters aged
15–17 or 18–20 than those aged 11–14 years, and among those whose annual household
income was at least $60,000. Non-Hispanic black mothers were less likely than non-
Hispanic white mothers to discuss HPV vaccine with their daughters.
Of mothers who talked with their daughters about HPV vaccine, almost half (47%, 231/496)
reported that doing so led to a discussion with their daughters about sex (Table 2). In
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multivariate analyses, communication about sex in the context of HPV vaccine was more
likely among mothers who reported being born-again Christians, lived in urban areas,
believed their daughters may be sexually active, or had greater knowledge of HPV vaccine.
Most mothers who talked with their daughters about HPV vaccine reported talking about
reasons for and against getting vaccinated against HPV (86%). Among mothers whose
daughters had received HPV vaccine, the majority (90%) reported having these discussions
prior to vaccination. Mothers most commonly reported discussing HPV vaccine benefits,
usually protection against cervical cancer (56%). They less frequently reported discussing
HPV vaccine negatives, including unknown long-term effects (12%) and potential or
perceived side effects such as painful injections (8%). We found few differences in content
by daughters’ vaccination status, in bivariate analyses (data available upon request).
Discussion
The vast majority of mothers in our sample had discussed HPV vaccine with their daughters,
consistent with a recent study conducted among adolescent girls [7]. A novel finding in our
study is that many mothers also discussed sex as a part of these conversations. Increasing
mothers’ communication about HPV vaccine with their pre-adolescent and young adolescent
daughters may, in turn, facilitate mother-daughter discussions about sexual health during
this important window of opportunity. While most mothers in our sample discussed HPV
vaccine with their daughters, some parents may be hesitant to do so precisely because they
feel unprepared or do not want to talk with their daughters about sex [8]. Health care
providers may be able to use HPV vaccination visits to provide guidance to parents about
discussing sexuality with their children, and to offer developmentally-appropriate sexual
health education and counseling directly to adolescents [9].
Our study’s main limitation is reliance on mothers’ reports, which may not fully reflect
actual conversations. Findings related to the content of discussions may over-emphasize
reasons for and against getting HPV vaccine based on the order of survey questions.
Additionally, as all mothers received a brief informative statement about HPV vaccine at
baseline, communication at follow-up may have been somewhat higher in our sample than
in the general population.
Our findings highlight the potential for HPV vaccine to facilitate sexual health promotion
and STI prevention efforts. For this strategy to be most successful, efforts should focus on
improving parents’ knowledge about HPV vaccine and encouraging parents of younger
adolescents to talk about HPV vaccine and sexual health with their children. Future research
is needed to explore how health care providers can capitalize on widespread HPV vaccine
implementation to provide sexual health and STI prevention messages to adolescents and
their parents.
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Table 1
Sample characteristics and mother-daughter communication about HPV vaccine, n=609




n (%) n (%) OR (95% CI) OR (95% CI)
Total 609 (100.0) 496 (81.4) - -
Daughter characteristics
Age
   11–14 years (Ref) 227 (37.3) 166 (73.1) 1.00 - 1.00 -
   15–17 years 218 (35.8) 184 (84.4) 1.99 (1.24–3.18)** 2.10 (1.22–3.63)**
   18–20 years 164 (26.9) 146 (89.0) 2.98 (1.68–5.27)*** 2.65 (1.40–5.02)**
Mother’s perception of daughter’s sexual
activity
Not sexually active (Ref) 312 (51.2) 251 (80.5) 1.00 -
May be sexually active 204 (33.5) 164 (80.4) 1.00 (0.61–1.55)
Sexually active 93 (15.3) 81 (87.1) 1.64 (0.84–3.20)
Mother characteristics
Age
   <45 years (Ref) 289 (47.5) 227 (78.6) 1.00 -
   45+ years 321 (52.6) 269 (83.8) 1.44 (0.96–2.17) 1.26 (0.78–2.03)
Race/ethnicity
   Non-Hispanic white (Ref) 449 (73.7) 383 (85.3) 1.00 - 1.00 -
   Non-Hispanic black 127 (20.9) 87 (68.5) 0.37 (0.24–0.59)*** 0.44 (0.26–0.76)**
   Hispanic or other 33 (5.4) 26 (78.8) 0.64 (0.27–1.53) 0.65 (0.24–1.77)
Education
   High school or less (Ref) 113 (18.6) 86 (76.1) 1.00 -
   Some college or more 496 (81.4) 410 (82.7) 1.50 (0.92–2.45)
Marital status
   Other (Ref) 83 (13.6) 63 (75.9) 1.00 -
   Married 526 (86.4) 433 (82.8) 1.48 (0.85–2.56)
Annual household income
   <$60,000 (Ref) 239 (39.2) 178 (74.5) 1.00 - 1.00 -
   $60,000+ 343 (56.3) 296 (86.3) 2.16 (1.41–3.30)*** 1.80 (1.11–2.93)*
   Missing 27 (4.4) 22 (81.5) 1.51 (0.55–4.16) 1.30 (0.41–4.11)
Born-again Christian
   No (Ref) 207 (34.0) 175 (84.5) 1.00 -
   Yes 402 (66.0) 321 (79.9) 0.72 (0.46–1.34)
Area of residence
   Rural (Ref) 304 (49.9) 247 (81.3) 1.00 -
   Urban 305 (50.1) 249 (81.6) 1.03 (0.68–1.54)
HPV vaccination
Daughter has initiated HPV vaccine
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n (%) n (%) OR (95% CI) OR (95% CI)
   No (Ref) 392 (64.4) 283 (72.2) 1.00 - 1.00 -
   Yes 217 (35.6) 213 (98.2) 20.51 (7.44–56.51)*** 11.20 (3.96–31.79)***
Doctor recommended daughter get HPV
vaccine
   No (Ref) 461 (75.7) 351 (76.1) 1.00 - 1.00 -
   Yes 148 (24.3) 145 (98.0) 15.15 (4.73–48.47)*** 6.64 (2.00–22.07)***
Parent believes daughter is in target age
group for HPV vaccination
   No (Ref) 46 (7.6) 30 (65.2) 1.00 - 1.00 -
   Yes 563 (92.5) 466 (82.8) 2.56 (1.34–4.88)** 1.44 (0.68–3.05)
HPV vaccine knowledge, mean (SD)b 0.66 (0.23) 0.68 (0.22) 8.76 (3.57–21.53)*** 3.81 (1.39–10.41)**
Note: Percents may not total 100% due to rounding. Multivariate model contains all correlates significant (p<.10) in bivariate models.
HPV=human papillomavirus; CI= confidence interval; OR= odds ratio; Ref= reference category; SD= standard deviation.
a
Answered yes to the question: “Have you ever talked with [daughter’s name] about HPV vaccine at all?”
b
Proportion of correct responses on 5 HPV vaccine knowledge items (range: 0–1). Component items included knowledge that HPV vaccine:
prevents most genital warts, prevents most cervical cancer, is recommended for 11–12 year old girls, works best if girls get it before they start
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Table 2
Mother-daughter communication about sex in the context of HPV vaccine discussions, n=496
Talked about sexa Bivariate Multivariate




   11–14 years (Ref) 76 (45.5) 1.00 -
   15–17 years 91 (49.5) 1.16 (0.76–1.76)
   18–20 years 64 (43.8) 0.92 (0.59–1.45)
Mother’s perception of daughter’s sexual
activity
   Not sexually active (Ref) 103 (41.0) 1.00 - 1.00 -
   May be sexually active 93 (56.7) 1.88 (1.26–2.80)*** 1.88 (1.25–2.83)**
   Sexually active 35 (43.2) 1.09 (0.59–1.81) 1.23 (0.73–2.09)
Mother characteristics
Age
   <45 years (Ref) 103 (45.0) 1.00 -
   45+ years 128 (46.5) 1.09 (0.77–1.56)
Race/ethnicity
   Non-Hispanic white (Ref) 173 (45.2) 1.00 -
   Non-Hispanic black 45 (51.7) 1.30 (0.82–2.07)
   Hispanic or other 13 (50.0) 1.21 (0.55–2.69)
Education
   High school or less (Ref) 38 (44.2) 1.00 -
   Some college or more 193 (47.1) 1.12 (0.70–1.79)
Marital status
   Other (Ref) 29 (46.0) 1.00 -
   Married 202 (46.7) 1.02 (0.60–1.74)
Annual household income
   <$60,000 (Ref) 87 (48.9) 1.00 - 1.00 -
   $60,000+ 138 (46.6) 0.91 (0.63–1.33) 0.93 (0.63–1.37)
   Missing 6 (27.3) 0.39 (0.15–1.04) 0.49 (0.18–1.34)
Born-again Christian
   No (Ref) 68 (38.9) 1.00 - 1.00 -
   Yes 163 (50.8) 1.62 (1.12–2.36)* 1.74 (1.17–2.58)**
Area of residence
   Rural (Ref) 100 (40.5) 1.00 - 1.00 -
   Urban 131 (50.6) 1.63 (1.14–2.33)* 1.75 (1.21–2.54)**
HPV vaccination
Daughter has initiated HPV vaccine
   No (Ref) 130 (45.9) 1.00 -
   Yes 101 (47.4) 1.06 (0.74–1.52)
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Talked about sexa Bivariate Multivariate
n (%) OR (95% CI) OR (95% CI)
Doctor recommended daughter get HPV
vaccine
   No (Ref) 159 (45.3) 1.00 -
   Yes 72 (49.7) 1.19 (0.81–1.75)
Parent believes daughter is in target age
group for HPV vaccination
   No (Ref) 12 (40.0) 1.00 -
   Yes 219 (47.0) 1.33 (0.63–2.82)
HPV vaccine knowledge, mean (SD)b 0.71 (0.22) 2.26 (1.02–5.02)* 2.46 (1.07–5.64)*
Note: Table presents findings among mothers who reported talking about HPV vaccine with their daughter. Multivariate model contains all
correlates significant (p<.10) in bivariate models. HPV=human papillomavirus; CI= confidence interval; OR= odds ratio; Ref= reference category;
SD= standard deviation.
a
Answered yes to the question: ‘Did talking about HPV vaccine with [name] lead to a conversation about sex?”
b
Proportion of correct responses on 5 HPV vaccine knowledge items (range: 0–1). Component items included knowledge that HPV vaccine:
prevents most genital warts, prevents most cervical cancer, is recommended for 11–12 year old girls, works best if girls get it before they start
having sex, and that women should continue to get pap smears after getting HPV vaccine.
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